
| ASSET | QUARTER | % RETURN |
|---|---|---|
AquaBounty Technologies (AQB) | Q1 2017 | 3,077,677.78% |
GT Biopharma (GTBP) | Q1 2017 | 1,689,552.17% |
Iqstel (IQST) | Q2 2017 | 4,056.1% |
Ocean Power Technologies (OPTT) | Q1 2017 | 1,383.22% |
Nixxy (NIXX) | Q3 2017 | 952.63% |
Focus Universal (FCUV) | Q4 2017 | 895.98% |
MDxHealth SA ADR (MDXH) | Q4 2017 | 760% |
Pulmatrix (PULM) | Q1 2017 | 523.21% |
Duos Technologies (DUOT) | Q1 2017 | 499.63% |
Riot Blockchain (RIOT) | Q4 2017 | 490.84% |
Castellum (CTM) | Q1 2017 | 431.58% |
GrabAGun Digital (PEW) | Q2 2017 | 421.32% |
Orion Digital (ORIO) | Q2 2017 | 386.37% |
Clean Energy Technologies, Inc Common Stock (CETY) | Q2 2017 | 375.68% |
Processa Pharmaceuticals (PCSA) | Q3 2017 | 328.57% |
Avalo Therapeutics (AVTX) | Q4 2017 | 280.95% |
Veritone (VERI) | Q3 2017 | 279.38% |
IZEA (IZEA) | Q3 2017 | 273.68% |
Cronos (CRON) | Q4 2017 | 270% |
Nutex Health (NUTX) | Q3 2017 | 266.67% |
Capricor Therapeutics (CAPR) | Q3 2017 | 265.06% |
Xunlei Ltd Adr (XNET) | Q4 2017 | 262.12% |
VerifyMe (VRME) | Q4 2017 | 254.8% |
Siebert Financial (SIEB) | Q4 2017 | 254.55% |
Lexaria Bioscience (LEXX) | Q4 2017 | 249.9% |